Insulin-like growth factor-1 receptor (IGF-1R) expression on circulating tumor cells (CTCs) and metastatic breast cancer outcome: results from the TransMYME trial.

Alessandra GennariFlavia FocaRita ZamarchiAndrea RoccaDino AmadoriAndrea De CensiAlessandra BolognaLuigi CavannaLorenzo GianniLaura ScaltritiElisabetta RossiAntonella FacchinettiVeronica MartiniPaolo BruzziOriana Nanni

Published in: Breast cancer research and treatment (2020)

Clinicaltrials.gov (NCT01885013); European Clinical Trials Database (EudraCT No.2009-014,662-26).

Keyphrases

circulating tumor cells
metastatic breast cancer
clinical trial
binding protein
phase ii
phase iii
growth hormone
poor prognosis
study protocol
circulating tumor
open label
pi k akt
randomized controlled trial
long non coding rna
cell proliferation